Skip to main content

Table 1 Demographic and clinical characteristics of included patients during MDT discussion

From: The efficiency of electronic list-based multidisciplinary team meetings in management of gastrointestinal malignancy: a single-center experience in Southern China

  eMDT group (n = 2156) cMDT group (n = 1518) P value
Including period 01/01/16–31/12/16 01/01/15–31/12/15  
 Age, years 55.4 ± 16.5 55.7 ± 16.5 0.529
 Gender, male to female 1617:539 1138:380 0.844
 BMI, kg/m2 20.3 ± 6.1 20.8 ± 6.5  
 Comorbidity, n(%)    0.695
  HTN 465(21.6) 310 (20.4)  
  DM 289 (13.4) 193 (12.7)  
  Othersa 86 (4.0) 59 (3.9)  
 Cancer type, n(%)    0.218
  Esophageal cancer 159 (7.4) 102 (6.7)  
  Gastric cancer 640 (29.7) 419 (27.6)  
  Colorectal cancer 1030 (47.8) 756 (49.8)  
  GIST 79 (3.7) 73 (4.8)  
  Othersb 332 (15.4) 209 (13.8)  
 Meeting times, n 45 46 NA
 Cases, n/month 172.3 ± 31.5 126.6 ± 42.7 0.004
 Treatment plan, n(%)    0.737
  Neoadjuvant therapy + surgery 305 (14.1) 205 (13.5)  
  Surgery 1583 (73.4) 1131 (74.5)  
  Palliative care 270 (12.5) 182 (12.0)  
 cTNM stage, n(%)    0.018
  I/II 1190 (55.2) 898 (59.2)  
  III/IV 966 (44.8) 620 (40.8)  
 pTNM stage, n(%)    0.098
  I/II 1226 (56.8) 821 (54.1)  
  III/IV 930 (43.2) 697 (45.9)  
  1. P value < 0.05 indicates significant difference
  2. eMDT electronic list-based MDT group, cMDT conventional MDT group, BMI body mass index, HTN hypertension, DM diabetes mellitus, GIST gastrointestinal stromal tumor, NA data not available
  3. aOther diseases include chronic obstructive pulmonary disease, atherosclerosis, and chronic liver or renal disease
  4. bOther cancers, such as pancreatic carcinoma, hepatic cancer, abdominal adenocarcinoma and peritoneal mesothelioma, were reviewed at the MDT meeting. Data are expressed as number (%) or as means ± SD, where appropriate